Skip to main content

Advertisement

SpringerLink
Log in

Treatment of adenovirus infections in the immunocompromised host

  • Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Adenovirus infections are increasing as causes of morbidity and mortality in severely immunocompromised patients. The currently available antiviral agents, ribavirin and cidofovir, have yielded mixed results in case reports and small case series. Similar to cytomegalovirus disease, established adenovirus disease is often difficult to treat. Therapy may yield poor results, even when effective antiviral drugs are used. New strategies, including pre-emptive therapy, should be tested in prospective, clinical trials. New agents and adoptive transfer of specific T-cells to adenovirus might improve the current situation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cooper RJ, Hallett R, Tullo AB, Klapper PE (2000) The epidemiology of adenovirus infections in greater Manchester, UK 1982–96. Epidemiol Infect 125:333–345

    Article  CAS  PubMed  Google Scholar 

  2. Singh-Naz N, Brown M, Ganeshananthan M (1993) Nosocomial adenovirus infection: molecular epidemiology of an outbreak. Pediatr Infect Dis J 12:922–925

    CAS  PubMed  Google Scholar 

  3. Venard V, Carret A, Corsaro D, Bordigoni P, Le Faou A (2000) Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved. J Hosp Infect 44:71–74

    Article  CAS  PubMed  Google Scholar 

  4. Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K, Schaefer UW, Roggendorf M, Holler E (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 28:51–57

    Article  CAS  PubMed  Google Scholar 

  5. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD (1985) Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 312:529–533

    CAS  PubMed  Google Scholar 

  6. Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M (2003) Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant 9:341–352

    Article  PubMed  Google Scholar 

  7. Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N, Casper JT (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169:775–781

    CAS  PubMed  Google Scholar 

  8. Lion T, Baumgartinger R, Watzinger F, Matthes-Martin S, Suda M, Preuner S, Futterknecht B, Lawitschka A, Peters C, Potschger U, Gadner H (2003) Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102:1114–1120

    Article  CAS  PubMed  Google Scholar 

  9. Hoffman JA, Shah AJ, Ross LA, Kapoor N (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7:388–394

    Article  CAS  PubMed  Google Scholar 

  10. Howard DS, Phillips IG, Reece DE, Munn RK, Henslee-Downey J, Pittard M, Barker M, Pomeroy C (1999). Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 29:1494–1501

    Article  CAS  PubMed  Google Scholar 

  11. La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, Raad I, Jacobson K, Kontoyiannis D, Elting L, Whimbey E (2001) Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 32:871–876

    Article  PubMed  Google Scholar 

  12. Baldwin A, Kingman H, Darville M, Foot AB, Grier D, Cornish JM, Goulden N, Oakhill A, Pamphilon DH, Steward CG, Marks DI (2000) Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 26:1333–1338

    Article  CAS  PubMed  Google Scholar 

  13. Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, Patrick CC (1999) Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23:277–282

    Article  CAS  PubMed  Google Scholar 

  14. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, Moss PA, Milligan DW (2002) Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100:1619–1627

    Article  CAS  PubMed  Google Scholar 

  15. Michaels MG, Green M, Wald ER, Starzl TE (1992) Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 165:170–174

    CAS  PubMed  Google Scholar 

  16. McGrath D, Falagas ME, Freeman R, Rohrer R, Fairchild R, Colbach C, Snydman DR (1998) Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J Infect Dis 177:459–462

    CAS  PubMed  Google Scholar 

  17. Meyers JD, Ljungman P, Fisher LD (1990) Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 162:373–380

    CAS  PubMed  Google Scholar 

  18. Keller EW, Rubin RH, Black PH, Hirsch MS, Hierholzer JC (1977) Isolation of adenovirus type 34 from a renal transplant recipient with interstitial pneumonia. Transplantation 23:188–191

    CAS  PubMed  Google Scholar 

  19. Stalder H, Hierholzer JC, Oxman MN (1977) New human adenovirus (candidate adenovirus type 35) causing fatal disseminated infection in a renal transplant recipient. J Clin Microbiol 6:257–265

    CAS  PubMed  Google Scholar 

  20. Ohori NP, Michaels MG, Jaffe R, Williams P, Yousem SA (1995) Adenovirus pneumonia in lung transplant recipients. Hum Pathol 26:1073–1079

    CAS  PubMed  Google Scholar 

  21. Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA (1998) Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 116:617–623

    CAS  PubMed  Google Scholar 

  22. Cavalli-Bjorkman N, Osby E, Lundin J, Kalin M, Osterborg A, Gruber A (2002) Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia. Med Oncol 19:277–280

    Article  PubMed  Google Scholar 

  23. Ljungman P, Ehrnst A, Björkstrand B, Hellström E, Ingelman SH, Juliusson G, Lönnqvist B (1990) Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia. Scand J Infect Dis 22:601–605

    CAS  PubMed  Google Scholar 

  24. Kaur B, Gottardo NG, Keil AD, Hallam LA, Baker DL (2002) A rare case of adenoviral fulminant hepatic necrosis after chemotherapy. Pediatr Hematol Oncol 19:361–371

    Article  PubMed  Google Scholar 

  25. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A (2001) Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 32:1290–1297

    Article  CAS  PubMed  Google Scholar 

  26. Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M, Saito H, Kojima S, Matsuyama T, Kitaori K, Nagafuji K, Sato T, Kodera Y (2000) Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25:545–548

    Article  CAS  PubMed  Google Scholar 

  27. Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D (2000) Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J 19:1097–1100

    CAS  PubMed  Google Scholar 

  28. Gavin PJ, Katz BZ (2002) Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110:e9

    PubMed  Google Scholar 

  29. Samarasinghe S, Cubitt D, Veys P (2002) Adenovirus infections during bone marrow transplantation. Royal College of Paediatrics and Child Health Sixth Spring Meeting, York, UK

  30. Morfin F, Dupuis-Girod S, Carrington D, Sedlacek P, Bierings M, Cetkovsky P, van Tol M, Thouvenot D. Adenovirus susceptibility to antiviral group is genotype-dependent. In: Program and abstracts. 43rd interscience conference on antimicrobial agents and chemotherapy, abstract no. 488

  31. Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M, Machaczka M, Bierings M, Bosi A, Gratecos N, Cordonnier C (2003) Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 31:481–486

    Article  CAS  PubMed  Google Scholar 

  32. Legrand F, Berrebi D, Houhou N, Freymuth F, Faye A, Duval M, Mougenot JF, Peuchmaur M, Vilmer E (2001) Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 27:621–626

    Article  CAS  PubMed  Google Scholar 

  33. Lion T, Matthes-Martin S, Suda M, Preuner S, Watzinger F, Lawitschka A, Peters C, Gadner H (2003) Intestinal adenovirus infection with increasing viral load in stool is an early indicator of impending disseminated disease in children undergoing T-cell depleted allogeneic stem cell transplantation. Blood 102:196a

    Article  Google Scholar 

  34. Hamel Y, Blake N, Gabrielsson S, Haigh T, Jooss K, Martinache C, Caillat-Zucman S, Rickinson AB, Hacein-Bey S, Fischer A, Cavazzana-Calvo M (2002) Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. Hum Gene Ther 13:855–866

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by the Swedish Children’s Cancer Fund.

Author information

Authors and Affiliations

  1. Department of Haematology, Karolinska University Hospital/Huddinge, Stockholm, 14186, Sweden

    P. Ljungman

Authors
  1. P. Ljungman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 23, 583–588 (2004). https://doi.org/10.1007/s10096-004-1165-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-004-1165-x

Keywords

Search

Navigation